Literature DB >> 14649310

Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.

Takeshi Takami1, Minori Shigematsu.   

Abstract

Hypertensive patients characteristically exhibit left ventricular (LV) hypertrophy and diastolic dysfunction. The effects of antihypertensive agents on LV hypertrophy and diastolic dysfunction do not always correlate with the degree of blood pressure reduction, but their effects on the sympathetic nervous system and renin-angiotensin system (RA system) are thought to be important. We investigated the effects of amlodipine and cilnidipine, N- and L-type calcium channel antagonists that suppress both blood pressure elevation and sympathetic activities, on LV hypertrophy and diastolic function. Patients with essential hypertension were randomly assigned to receive either amlodipine, cilnidipine or nifedipine CR (which does not block N-type calcium channels) for 6 months. The LV mass index was determined using M-mode echocardiography. The E/A ratio, i.e., the ratio of maximum amplitude between the early diastolic wave (E wave) and the atrial systolic wave (A wave) in the LV inflow pattern, and the deceleration time for the E wave were determined using pulse Doppler echocardiography. Systolic and diastolic blood pressures significantly decreased from the baseline values in all three groups, with no significant differences among the groups. The LV mass index had significantly decreased when it was evaluated 3 months after the initiation of treatment in the cilnidipine group and when it was evaluated 6 months after the initiation of treatment in the amlodipine group; only a slight decrease was observed in the nifedipine CR group. A significant decrease in the deceleration time and a significant increase in the E/A ratio were observed after 3 months of treatment in the cilnidipine and amlodipine groups but not in the nifedipine CR group. Thus, the effects of long-acting calcium channel antagonists on hypertensive LV hypertrophy and LV diastolic function varied from one antagonist to the other. Left ventricular hypertrophy and diastolic function improved in the cilnidipine and amlodipine groups, but not in the nifedipine CR group. These results indicate that the suppression of sympathetic nerve activity by the blockade of N-type calcium channels contributes to the improvement of LV hypertrophy and diastolic function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649310     DOI: 10.1081/ceh-120025336

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 2.  Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention.

Authors:  Takeshi Takami; Satoshi Hoshide; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-10-08       Impact factor: 3.872

3.  Evaluation of aortic stiffness in children with chronic renal failure.

Authors:  Ali Rahmi Bakiler; Onder Yavascan; Nilgun Harputluoglu; Orhan Deniz Kara; Nejat Aksu
Journal:  Pediatr Nephrol       Date:  2007-08-21       Impact factor: 3.714

4.  Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.

Authors:  Kun Zhang; Feifei Huang; Jie Chen; Qingqing Cai; Tong Wang; Rong Zou; Zhiyi Zuo; Jingfeng Wang; Hui Huang
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

5.  Impact of Arterial Hypertension on Left Atrial Size and Function.

Authors:  Youssef Ikejder; Majda Sebbani; Iliass Hendy; Mounia Khramz; Ali Khatouri; Laila Bendriss
Journal:  Biomed Res Int       Date:  2020-09-14       Impact factor: 3.411

6.  Studies to Elucidate the Mechanism of Cardio Protective and Hypotensive Activities of Anogeissus acuminata (Roxb. ex DC.) in Rodents.

Authors:  Fatima Saqib; Muhammad Arif Aslam; Khizra Mujahid; Luigi Marceanu; Marius Moga; Hanadi Talal Ahmedah; Liana Chicea
Journal:  Molecules       Date:  2020-07-30       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.